首页> 外文期刊>Journal of Biotechnology >The preparation of porcine circovirus type 2 (PCV2) virus-like particles using a recombinant pseudorabies virus and its application to vaccine development
【24h】

The preparation of porcine circovirus type 2 (PCV2) virus-like particles using a recombinant pseudorabies virus and its application to vaccine development

机译:利用重组伪狂犬病病毒制备猪圆环病毒2型(PCV2)病毒样颗粒及其在疫苗开发中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

Porcine circovirus type 2 (PCV2) is the primary causative agent of an economically important swine disease, now known as porcine-associated disease (PCVAD). The only structural protein of viral capsid, Cap has become the major target for development of PCV2 subunit vaccines. The purpose of this study is to express Cap of PCV2 using a recombinant pseudorabies virus (PRV) that is gE gene deficient, which is a widely used PRV marker vaccine. The recombinant PRV, gE(-)PCV2cap(+)PRV, was constructed using homologous recombination techniques, in order to replace the upstream of the gE gene with the PCV2 cap gene. The expression of Cap during virus replication was confirmed using immunofluorescence and Western blotting analysis. The expressed Cap protein self-assembled into virus-like particles (VLPs), which was demonstrated using electromicrography. The immunization of mice or guinea pigs with purified VLPs could induce significant, specific antibody responses to PCV2 Cap. These results demonstrate an alternative to PCV2 for the development of a VLP-based subunit vaccine
机译:猪圆环病毒2型(PCV2)是经济上重要的猪疾病(现称为猪相关疾病(PCVAD))的主要病原体。 Cap是病毒衣壳的唯一结构蛋白,已成为开发PCV2亚基疫苗的主要目标。这项研究的目的是使用gE基因缺陷的重组伪狂犬病病毒(PRV)表达PCV2的Cap,这是一种广泛使用的PRV标记疫苗。使用同源重组技术构建重组PRV gE(-)PCV2cap(+)PRV,以用PCV2 cap基因替代gE基因的上游。使用免疫荧光和蛋白质印迹分析确认了病毒复制过程中Cap的表达。表达的Cap蛋白自组装成病毒样颗粒(VLP),这已通过电子显微术证实。用纯化的VLP免疫小鼠或豚鼠可以诱导对PCV2 Cap的显着特异性抗体反应。这些结果证明了PCV2的替代品可用于开发基于VLP的亚单位疫苗

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号